Perampanel and brivaracetam are effective for the add-on treatment of focal-onset seizures and display similar adverse event profiles.
As innovations in neurotechnology for epilepsy emerge, understanding of individual and societal values is essential to their beneficial evolution and translation to care.
Current CURE Grantees are finding ways to continue their studies, but with severe restrictions on laboratory access, many researchers have had to limit or stop their work.
Compared with those with epileptic seizures, patients and caregivers living with PNES experience stigma more frequently and to a higher extent.
Safety was similar and clinical seizure outcomes exceeded those of the prospective clinical trials, corroborating effectiveness of this therapy and suggesting that clinical experience has informed more effective programming of the RNS device.
These results highlight the importance of assessing the family environment during presurgical evaluation and implementing early family-based intervention and supports to promote better outcomes for children in the long term.
Emergency departments will frequently call a stroke alert for patients taking LTG and having symptoms consistent with LTG toxicity.
By moving the diagnostic process out of the hospital or epilepsy center, it becomes possible to overcome growing gaps in neurology services.
This study investigated the effect of delayed or missed doses on the metabolism of valproic acid in patients with epilepsy and established remedial dosing recommendations for nonadherent patients.
